EVPL and chronic myelogenous leukemia, BCR-ABL1 positive: A recent study involving 250 Mexican Ph-positive CML patients [70] reported that 90.4% of patients expressed p210 BCR-ABL1, and just about 7% of patients with p210 BCR-ABL1 expressed both isoform (b3a2/b2a2) [70].